Compare NEXT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXT | RXRX |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2014 | 2021 |
| Metric | NEXT | RXRX |
|---|---|---|
| Price | $7.73 | $3.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $8.00 | $7.50 |
| AVG Volume (30 Days) | 2.3M | ★ 19.8M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $4.75 | $2.77 |
| 52 Week High | $12.12 | $7.18 |
| Indicator | NEXT | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 49.58 |
| Support Level | $6.53 | $2.85 |
| Resistance Level | $8.93 | $4.01 |
| Average True Range (ATR) | 0.40 | 0.31 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 9.58 | 32.96 |
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.